Medical Cannabis, hEDS, and the Sensitized Nervous System with Professor Dave Nutt & Lucy Stafford (Ep 206)

Why do some people with hEDS or HSD report meaningful relief with medical cannabis, while others feel worse, notice no benefit, or experience side effects? And what might these varied responses teach us about pain, the autonomic nervous system, gut function, and nervous system sensitization?

In this episode, host Dr. Linda Bluestein, the Hypermobility MD, is joined by Professor David Nutt, a neuropsychopharmacologist at Imperial College London, and Lucy Stafford, a PhD researcher in clinical neuroscience with lived experience of hypermobile Ehlers-Danlos syndrome.

This is not a hype episode, a recommendation to use cannabis, or medical advice. Instead, it is a careful, curiosity-driven conversation about what is known, what is still emerging, and what remains uncertain about medical cannabis in hEDS and HSD.

Lucy shares her experience of severe illness, high-dose opioid treatment, a feeding tube, repeated ICU stays, and eventually coming off opioids, an experience that helped shape her path into cannabinoid research. Professor Nutt explains the discovery of the endocannabinoid system and why this system may be relevant to pain processing, stress responses, autonomic regulation, immune signaling, and gut function.

Together, they explore how cannabinoids may influence a sensitized nervous system, why responses vary so widely, and why medically complex patients need individualized guidance rather than shame, dismissal, or unsupported promises.

The conversation covers many of the practical questions patients often ask, including the difference between CBD and THC, full-spectrum products, terpenes and the entourage effect, routes of administration, absorption differences, and the importance of a cautious “start low, go slow” approach when cannabis is being considered under appropriate medical supervision.

They also address important safety considerations, including contraindications, drug interactions, psychiatric risk, impairment, dependence, and why cannabis is not appropriate for everyone. The episode closes with a broader discussion of stigma, the emerging science of psychedelics for chronic pain, and the human and financial costs of undertreated complex illness.

The Bendy Bodies podcast is for educational purposes only and is not a substitute for personalized medical advice. Laws, product quality, dosing, and individual risks vary, so patients should consult a qualified healthcare professional before using cannabis or changing any treatment pla